A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes

Authors

G. Viberti
S.E. Kahn
D.A. Greene
W.H. Herman
B. Zinman

Document Type

Journal Article

Publication Date

2002

Journal

Diabetes Care

Volume

25

Inclusive Pages

1737-1743

Keywords

Epidemiology & Biostatistics

APA Citation

Viberti, G., Kahn, S., Greene, D., Herman, W., & Zinman, B. (2002). A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes. Diabetes Care, 25 (). Retrieved from https://hsrc.himmelfarb.gwu.edu/sphhs_epibiostats_facpubs/718